A Rare Case Report of Disseminated Nocardia Farcinica Granulomatous Hepatitis and Clinical Management Experience
DOI: https://doi.org/10.2147/idr.s461494
2024-04-18
Infection and Drug Resistance
Abstract:Rui Juan Song, Guang Lin Zhang Department of Infectious Diseases, Anhui Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Hefei, People's Republic of China Correspondence: Guang Lin Zhang, Department of Infectious Diseases, Anhui Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Hefei, People's Republic of China, Email Background: Nocardiosis is primarily an opportunistic infection affecting immunocompromised individuals, with a predilection for the lungs, brain, or skin in those with compromised immune function. Granulomatous hepatitis caused by Nocardia is a rare clinical manifestation. This study aims to provide a systematic overview of the clinical features of Nocardiosis caused by Nocardia farcinica, enhancing our understanding of this disease. Methods: We report a case of a 75-year-old male with no underlying diseases presenting with a history of "recurrent fever for more than 4 months", along with fatigue, poor appetite, and pleural and abdominal effusion. Despite treatment at multiple hospitals, the patient showed little improvement. Chest CT revealed chronic inflammation, small nodules, bilateral pleural effusion, and pleural thickening. Abdominal CT indicated multiple low-density lesions in the liver, multiple small calcifications, and abdominal effusion. Results: Liver biopsy suggested inflammatory changes, with focal granuloma formation. Metagenomic next-generation sequencing (mNGS) of liver tissue indicated Nocardia farcinica, leading to the final diagnosis of disseminated Nocardia farcinica granulomatous hepatitis. Conclusion: Nocardia infection is a rare disease primarily observed in immunocompromised patients but can also occur in those with normal immune function. The clinical and radiological features lack specificity; however, the utilization of mNGS technology enables rapid identification of the pathogenic microorganism. Nocardia farcinica is generally susceptible to sulfonamide drugs and amikacin, offering viable treatment options. Keywords: nocardia farcinica, granulomatous hepatitis, disseminated infection, mNGS Technology, TMP-SMX Nocardiosis, caused by members of the Nocardia genus, is a rare yet potentially life-threatening infectious disease. It primarily occurs in individuals with compromised or suppressed immune systems but can also infect those with normal immune function. 1 The pathogen primarily enters through inhalation via the respiratory tract or direct invasion through the skin and soft tissues. Common sites of infection include the lungs, skin, and central nervous system. Disseminated infections involving multiple organ systems are less frequent but can pose a life-threatening risk. 2 Nocardia species as well as the invasiveness of each one may depend on geographic variations. 3 Nocardia farcinica constitutes 24.5% of all Nocardia infections, and it is more prone to causing disseminated infections with a higher mortality rate. 4 Nocardia, as a pathogen affecting humans, receives relatively less attention. Due to challenges in its discovery and diagnosis, there is often a delay in treatment, leading to unfavorable prognoses. 4 This study reports a case of an immunocompetent patient who developed granulomatous hepatitis due to Nocardia farcinica infection. Patient, male, 75 years old. The patient began experiencing intermittent fever in April 2023, with fever occurring 1–2 times per week and reaching a peak temperature of 38°C. He presented with fatigue and poor appetite, without cough or sputum symptoms. In July 2023, the fever became more frequent, with a peak temperature of 39.1°C. Hospital examinations revealed decreased white blood cell count, elevated erythrocyte sedimentation rate, decreased albumin, reduced white cell ratio, blood and protein in urine. Blood culture detected Staphylococcus saprophyticus, while sputum and urine cultures were negative.Chest CT scans showed chronic inflammation, Small nodules in both lungs, bilateral pleural effusion, and pleural thickening (Figure 1). Abdominal CT indicated multiple low-density lesions in the liver and spleen, with multiple small calcifications in both organs (Figure 2). A cyst was observed in the right kidney, along with abdominal effusion. Consider the presence of Staphylococcus saprophyticus infection. The patient sought treatment in multiple hospitals and received ineffective antimicrobial therapy including cephalosporins, piperacillin-tazobactam, and meropenem. These treatments are not effective. In August 2023, a liver biopsy was performed, revealing focal granuloma formation suggestive of inflammatory lesions. Tuberculosis infection T-cell testing was positive, leading to the initiation of empirical anti-tuberculosis treatm -Abstract Truncated-
pharmacology & pharmacy,infectious diseases